+ Follow RDL Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 104282
[Title] => Beauty products’ maker complies with BFAD rules
[Summary] => The management of RDL Pharmaceutical Laboratory Inc. stressed that they have consistently complied with all the rules, regulations and guidelines of the Bureau of Food and Drugs (BFAD) since they started operations in 1995.
"We have always adhered to all requirements in our operations and we have continuously complied with all the rules and laws pertaining to our operations," said Evelyn Elemino, RDL vice president.
[DatePublished] => 2001-05-24 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Nation
[SectionUrl] => nation
[URL] =>
)
[1] => Array
(
[ArticleID] => 99830
[Title] => Beauty products’ maker complies with BFAD rules
[Summary] => The management of RDL Pharmaceutical Laboratory Inc. stressed that they have consistently complied with all the rules, regulations and guidelines of the Bureau of Food and Drugs (BFAD) since they started operations in 1995.
"We have always adhered to all requirements in our operations and we have continuously complied with all the rules and laws pertaining to our operations," said Evelyn Elemino, RDL vice president.
[DatePublished] => 2001-05-23 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Nation
[SectionUrl] => nation
[URL] =>
)
[2] => Array
(
[ArticleID] => 90634
[Title] => Beauty product poses health risk, tests show
[Summary] => Health experts from the UP Natural Sciences and Research Institute have determined that a beauty product being sold in the market contains strong acids that pose a grave health risk to users.
Recent tests confirmed that the pH balance of Special RDL Babyface Astringent is only 1.89 when the safe and allowed pH balance level for astringents should not be less than 2.
[DatePublished] => 2001-05-13 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[3] => Array
(
[ArticleID] => 90568
[Title] => ‘Adulterated’ beauty product still being sold
[Summary] => A beauty product, earlier found by the Bureau of Food and Drugs (BFAD) to have deviated from its indicated formulation, has been allowed to be sold to the public despite the possible public health risk involved.
A BFAD report said the RDL Babyface Astringent, was "not only adulterated but also misbranded" and that its factory in Davao City did not comply with the bureau’s "good manufacturing practice (GMP) policy" to make sure products are clean and of high quality to protect public health.
[DatePublished] => 2001-05-04 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[4] => Array
(
[ArticleID] => 86328
[Title] => BFAD warns company
[Summary] => Bureau of Food and Drugs (BFAD) director William Torres warned the manufacturer of an astringent with cancellation of its license if it commits a third violation of BFAD regulations.
In a recent radio interview, Torres said RDL Pharmaceutical Laboratory in Davao City erred when it marketed the Special RDL Babyface Astringent, a whitening product, without the necessary certificate of registration.
[DatePublished] => 2001-04-29 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1194024
[AuthorName] => by Ella Oducayen
[SectionName] => Nation
[SectionUrl] => nation
[URL] =>
)
[5] => Array
(
[ArticleID] => 104091
[Title] => BFAD warns company
[Summary] => Bureau of Food and Drugs (BFAD) director William Torres warned the manufacturer of an astringent with cancellation of its license if it commits a third violation of BFAD regulations.
In a recent radio interview, Torres said RDL Pharmaceutical Laboratory in Davao City erred when it marketed the Special RDL Babyface Astringent, a whitening product, without the necessary certificate of registration.
[DatePublished] => 2001-04-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1194024
[AuthorName] => by Ella Oducayen
[SectionName] => Nation
[SectionUrl] => nation
[URL] =>
)
)
)
RDL
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 104282
[Title] => Beauty products’ maker complies with BFAD rules
[Summary] => The management of RDL Pharmaceutical Laboratory Inc. stressed that they have consistently complied with all the rules, regulations and guidelines of the Bureau of Food and Drugs (BFAD) since they started operations in 1995.
"We have always adhered to all requirements in our operations and we have continuously complied with all the rules and laws pertaining to our operations," said Evelyn Elemino, RDL vice president.
[DatePublished] => 2001-05-24 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Nation
[SectionUrl] => nation
[URL] =>
)
[1] => Array
(
[ArticleID] => 99830
[Title] => Beauty products’ maker complies with BFAD rules
[Summary] => The management of RDL Pharmaceutical Laboratory Inc. stressed that they have consistently complied with all the rules, regulations and guidelines of the Bureau of Food and Drugs (BFAD) since they started operations in 1995.
"We have always adhered to all requirements in our operations and we have continuously complied with all the rules and laws pertaining to our operations," said Evelyn Elemino, RDL vice president.
[DatePublished] => 2001-05-23 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Nation
[SectionUrl] => nation
[URL] =>
)
[2] => Array
(
[ArticleID] => 90634
[Title] => Beauty product poses health risk, tests show
[Summary] => Health experts from the UP Natural Sciences and Research Institute have determined that a beauty product being sold in the market contains strong acids that pose a grave health risk to users.
Recent tests confirmed that the pH balance of Special RDL Babyface Astringent is only 1.89 when the safe and allowed pH balance level for astringents should not be less than 2.
[DatePublished] => 2001-05-13 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[3] => Array
(
[ArticleID] => 90568
[Title] => ‘Adulterated’ beauty product still being sold
[Summary] => A beauty product, earlier found by the Bureau of Food and Drugs (BFAD) to have deviated from its indicated formulation, has been allowed to be sold to the public despite the possible public health risk involved.
A BFAD report said the RDL Babyface Astringent, was "not only adulterated but also misbranded" and that its factory in Davao City did not comply with the bureau’s "good manufacturing practice (GMP) policy" to make sure products are clean and of high quality to protect public health.
[DatePublished] => 2001-05-04 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[4] => Array
(
[ArticleID] => 86328
[Title] => BFAD warns company
[Summary] => Bureau of Food and Drugs (BFAD) director William Torres warned the manufacturer of an astringent with cancellation of its license if it commits a third violation of BFAD regulations.
In a recent radio interview, Torres said RDL Pharmaceutical Laboratory in Davao City erred when it marketed the Special RDL Babyface Astringent, a whitening product, without the necessary certificate of registration.
[DatePublished] => 2001-04-29 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1194024
[AuthorName] => by Ella Oducayen
[SectionName] => Nation
[SectionUrl] => nation
[URL] =>
)
[5] => Array
(
[ArticleID] => 104091
[Title] => BFAD warns company
[Summary] => Bureau of Food and Drugs (BFAD) director William Torres warned the manufacturer of an astringent with cancellation of its license if it commits a third violation of BFAD regulations.
In a recent radio interview, Torres said RDL Pharmaceutical Laboratory in Davao City erred when it marketed the Special RDL Babyface Astringent, a whitening product, without the necessary certificate of registration.
[DatePublished] => 2001-04-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1194024
[AuthorName] => by Ella Oducayen
[SectionName] => Nation
[SectionUrl] => nation
[URL] =>
)
)
)
abtest
